Sunstone Life Science Ventures venture capital and private equity firm investing in companies developing novel therapeutics for humans in Europe that is headquartered in Copenhagen, Denmark and was founded in 2007 by Søren Lemonius, Søren Lemonius, Søren Lemonius, Sten Verland, and Sten Verland.
Sunstone Life Science Ventures invests in life science companies developing therapeutics for humans; with a special interest in investing in companies developing specialty pharmaceuticals and orphan drugs. The firm does not invest in medical technologies such as medical diagnostic technologies. Sunstone Life Science Ventures focuses on investing in companies with clear exit strategies because it believes the most exits in the life science industry will occur through mergers and acquisitions.
Notable investments made by Sunstone Life Science Ventures include: IO Biotech, OxThera, Antargia, Adenium Biotech, Minervax, Galecto Biotech, Alligator Biosciences, Zeal & Revolutionary Health Solutions, Vaximm, Orphazyme, Ascella Pharma, Nuevolution, Symphogen, Evolva, Arcoma, FBC Device, Acarix, and Jenavalve.
Rigontec GmbH is a biotechnology company and developer of technology for accessing the retinoic acid-inducible gene pathway.
IO Biotech is a Copenhagen-based company founded in 2014 by Mai-Britt Zocca, PhD, Professor Mads Hald Andersen, Anders Ljungqvist, Professor MD PhD Inge Marie Svane and Professor Per Thor Straten.
JenaValve Technology is an Irvine, California-based company.
Acarix is a Malmö-based company manufacturing diagnostic systems for coronary artery disease.